Serena Bertolini
Corporate Pre Clinical R&D
Parma, 43122, Italy
Parma, 43122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPF.
Journal: Journal of medicinal chemistry
Published: February 20, 2026
A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPF.
Journal: Journal of medicinal chemistry
Published: February 20, 2026
Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease.
Journal: Journal of medicinal chemistry
Published: December 05, 2024
Discovery and Optimization of Pyridazinones as PI3Kδ Selective Inhibitors for Administration by Inhalation.
Journal: Journal of medicinal chemistry
Published: June 22, 2024
Application of an "inhalation by design" approach to the identification and in-vitro evaluation of novel purine based PI3Kδ inhibitors.
Journal: European journal of medicinal chemistry
Published: November 02, 2022
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases.
Journal: Science translational medicine
Published: March 30, 2022
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs.
Journal: Journal of medicinal chemistry
Published: May 11, 2017
Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: September 18, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026